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Anti-GBM nephritis in the mouse: Role of granulocytes in the heterol-
ogous phase. The role of polymorphonuclear granulocytes (PMNs) was
studied in a model of anti-GBM nephritis in mice, in which PMN
depletion was induced by total body irradiation of 7.5 Gy. Both in
complement-normal BlO.D2 new and in CS-deficient B10.D2 old mice,
PMN depletion completely prevented the albuminuria occurring after
injection of low doses of anti-GBM serum, and severely depressed the
albuminuria after injection of high doses. In immunofluorescence,
glomerular deposition of antibody and C3 was similar to that in control
mice. The glomerular influx of PMNs in both the complement-normal
and C5-deficient controls was inhibited to 10% or less of control values.
Fibrin deposition or necrosis did not occur. Injection of F(ab')2 frag-
ments of the anti-GBM antibody in non-irradiated mice caused only
limited PMN influx and reduced the albuminuria to physiological levels,
although the binding of 1251 labeled F(ab')2 fragments to the glomeruli
was as high as 82% of that of the complete antibody. We conclude that
the albuminuria in this model is Fc-dependent and largely, if not
completely, dependent on the influx of PMNs in the glomeruli. Among
the many experimental models of anti-GBM nephritis, this is the first
one in which the heterologous phase is complement-independent but
PMN-dependent.
Insight in the pathogenesis of human glomerulonephritis has
been greatly enhanced by studies in experimental models.
Among these the model of anti-glomerular basement membrane
(anti-GBM) nephritis, is one of the oldest and most extensively
studied [1]. In the classical model of anti-GBM nephritis intra-
venous (i.v.) injection of heterologous antibody against the
GBM induces glomerular damage, initiated by binding of the
antibody to the GBM, followed by activation of complement,
accumulation of polymorphonuclear granulocytes (PMNs),
deposition of fibrin, and necrosis of the glomerular capillaries.
This early reaction of the so-called heterologous phase is
accompanied by a dose-dependent proteinuria. After five to
seven days a second phase develops, caused by the binding of
autologous antibodies to the heterologous immunoglobulins
already deposited along the GBM.
Especially the heterologous phase of anti-GBM nephritis,
with its characteristic histological picture of an acute inflamma-
tory reaction, has been studied in several species and has
provided an opportunity to test the influence of antibodies of
different types and origin, and the role of inflammatory media-
tor systems in the development of the eventual glomerular
damage. It has become clear that the pathogenic mechanisms in
this relatively simple model are complex and variable. The role
of mediator systems, such as the complement system and
PMNs, is dependent on animal species and on type, class, and
charge of the antibodies that are used [reviewed in 2]. The
original hypothesis that the glomerular damage in anti-GBM
nephritis is brought about by a sequence of events similar to
that of the Arthus reaction [31, that is, binding of antibody to
antigen, activation of complement, attraction of PMNs, and
ultimate damage by lysosomal enzymes and oxygen radicals,
seems not to be applicable to a number of models of glomeru-
lonephritis in which either complement or PMNs were shown
not to be essential mediators in the development of tissue
damage [2]. On the other hand, in those models in which PMNs
are essential, these cells are usually attracted via complement
activation.
As reported earlier, we have developed a classical model of
anti-GBM nephritis in the mouse, with a reproducible dose-
dependent albuminuria, developing within six hours after injec-
tion of goat or rabbit anti-GBM serum, and characterized by
signs of acute inflammation in the glomeruli with deposition of
antibody, activation of complement, PMN influx, intravascular
coagulation and necrosis [4]. In contrast with this classical
picture, however, neither the albuminuria nor the histological
lesions in the heterologous phase proved to be complement-
dependent [5].
The present study shows that in this complement-indepen-
dent model PMNs are required for the development of the
glomerular lesions. It is the first report of a PMN-dependent/
complement-independent mechanism in the heterologous phase
of anti-GBM nephritis.
Methods
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BlO.D2 new strain and congenitally CS-deficient Bl0.D2 old
strain mice, originally obtained from the Jackson Laboratory,
Bar Harbor, Maine, USA, were kept in our laboratory by
continuous brother-sister matings. Only male mice were used,
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at ages of three to four months. Randomly-bred Swiss mice
were purchased from the Central Institute for the breeding of
laboratory animals, TNO, Zeist, The Netherlands. For the
preparation of the anti-GBM antisera we used a goat and New
Zealand white rabbits, bought from a local breeder.
Anti-GBM sera
For the in vivo studies of the nephritogenic effects we used a
goat anti-mouse-GBM antiserum. For the quantitative studies
of glomerular binding a second antiserum was prepared in
rabbits. The immunization procedures, using a GBM suspen-
sion prepared from Swiss mouse kidneys, the purification of the
IgG fractions of the antisera, as well as the assessment of purity
and specificity were carried out as reported before [4]. The IgG
fraction of the goat antiserum was concentrated to 75 mg
protein/mI, and the protein content of the rabbit IgG prepara-
tion was 26 mg/mi, both determined according to the method of
Lowry et al [61. Non-immune rabbit IgG was prepared from
normal rabbit serum by the same procedure and concentrated to
26 mg/mI.
F(ab')2 fragments
F(ab')2 fragments of both the goat and rabbit anti-mouse-
GBM antiserum were prepared by digestion with pepsin as
described by Nisonoff [7]. Briefly, the IgG preparation was
dialyzed for four hours at room temperature against 0.1 M
sodium acetate buffer, pH 4.0. Pepsin was added at a ratio of 1
mg/l00 mg IgG. Digestion was allowed to proceed at 37°C for 20
hours, and the precipitate was removed by centrifugation (10
mm, 2000 g). The supernatant was dialyzed against phosphate-
buffered saline (PBS), pH 7.4 for four hours, concentrated, and
fractionated by gel chromatography on a 80 x 2 cm Ultrogel
ACA-34 column (LKB products, Bromma, Sweden) with a
separation range of 20 to 400 kD. Two major peaks with
extinction at 280 nm were collected. Polyacrylamide gel elec-
trophoresis (PAGE) analysis showed that the first peak con-
tained undigested IgG and F(ab')2, and the second low molec-
ular weight material. The material in the first peak was pooled,
concentrated, and passed over an Ultrogel ACA-44 column
(separation range 10 to 130 kD). Two elution peaks were
observed and PAGE-analysis demonstrated that the second
peak of the goat anti-GBM antibody contained 95% and that of
the rabbit antibody 97% pure F(ab')2 fragments. In both sera the
undigested IgG was present in the first peak. The material in the
F(ab')2 peaks was pooled and concentrated to a final concen-
tration of 37 mg/mI for the goat antibody and 25 mg/ml for the
rabbit antiserum, as measured in a Lowry assay [61. The
molecular weights of F(ab')2 and undigested IgG could be
determined from the PAGE patterns by comparison with simul-
taneously applied marker proteins (Pharmacia, Uppsala, Swe-
den). We found that the F(ab')2 fragments of both antisera had
approximately half the molecular weight of the undigested IgG
molecules. Equimolar doses of the F(ab')2 fragments, therefore,
contain half the amount of protein of the intact IgG.
Radiolabeling
Radiolabeling of undigested rabbit anti-mouse IgG, the
F(ab')2 fragments thereof, and of normal rabbit IgG was per-
formed with 125J using lodo beads (Pierce Chemical Co.,
Rockford, Illinois, USA) as a coupling reagent [8], to a specific
activity of 0.02 to 0.04 mCi/mg protein [9]. Free zI was
removed by Sephadex G25 chromatography and unlabeled IgG
or F(ab')2 fragments were added to obtain the desired protein
concentration. The specific activity of the final samples was
determined immediately before injection into the mice.
PMN-depletion
Mice were depleted of PMNs by total body irradiation (TB!).
Irradiation was given in a single dose of 7.5 Gy, at a dose rate
of 2 Gy/min, with a 13 MeV electron beam, from a linear
accelerator (CGR Saturne, Buc, France), at four days before
injection of the anti-GBM serum. Pretreatment of the mice, the
method of irradiation, and antiseptic treatment were as de-
scribed before [10]. By day 4 after irradiation, that is, at the
time of maximal PMN depletion, many mice had lost up to 20%
of their body weight, and showed a lowering of skin tempera-
ture, but otherwise the animals remained in excellent condition
throughout the period of the experiments.
Experimental protocol
At day 4 after TBI complement-normal B lO.D2 new mice and
CS-deficient B 10.D2 old mice were injected intravenously with
5.6 mg (low dose) or 22.5 mg (high dose) of goat anti-mouse
GBM serum. The extent of glomerular protein leakage was
determined in urine samples collected by bladder puncture at
two hours and six hours after injection of the antibody, and in
18 hour samples of urine obtained by placing the animals in
individual metabolic cages from 6 to 24 hours after injection.
Since both irradiated and non-irradiated mice showed a ten-
dency to dehydration and weight loss during this period, all
mice received 1 ml 0.9% saline, intraperitoneally, immediately
before they were put into metabolic cages, wherein they only
received water ad libitum. For determination of circulating
leukocyte and platelet numbers, and concentrations of serum
albumin, creatinine and urea, blood was drawn from the retro-
bulbar plexus at two hours, six hours, 24 hours, and at day 4
after administration of the antiserum. After bleeding, the kid-
neys were taken for histological examination.
The studies with the F(ab')2 fragments of the goat anti-GBM
serum were carried out only in the complement-normal B 10.D2
new mice. Of these animals urine samples were collected at two
hours by bladder puncture and as 18 hour samples after
placement of the mice in metabolic cages from 6 to 24 hours
after injection of the F(ab')2 antibodies. For histological exam-
ination kidneys were taken at two hours and 24 hours after
injection.
Laboratory and hematological examinations
Urinary albumin concentrations were determined by radial
immunodiffusion, using a 50% ammonium sulphate precipitate
of goat antiserum against albumin as described before [4].
Serum albumin concentrations were determined by the brom-
cresol green method [11]. Serum urea and creatinine were
measured in a CoBas Bio autoanalyzer (Roch, Basel, Switzer-
land). Serum complement activity was measured in a sensitive
hemolytic assay, based on the method described by Berden,
Hagemann and Koene [12], with modifications designed to
make it applicable to smaller blood volumes and to increase the
sensitivity [13]. Using this assay we tested the effect of TB! on
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complement levels and confirmed the complement deficiency of
the Bl0.D2 old mice.
Leukocytes were counted in a Coulter Counter (Coulter
Electronics Ltd, Luton Beds, England, UK) and differential
counts determined in air dried May-Grunwald-Giemsa stained
smears. Platelets were counted in a Baker 820 platelet counter
(Baker Instruments, Deventer, The Netherlands).
Light microscopy
Kidney fragments were fixed in Bouin's solution, dehydrated
and embedded in paraplast (Amstelstad, Amsterdam, The
Netherlands) and 4 tm sections were stained with hematoxylin
and eosin, Periodic Acid Schiff and silver methenamine. The
glomerular influx of PMNs was determined semi-quantitatively
by counting, in three mice per observation point, the total
number of PMNs in at least 40 glomeruli, located in adjacent
high power fields in the central part of the renal cortex, and
expressed as the average number of PMNs per glomerulus.
Immunohistology
For determination of the deposition of immunoglobulins, C3
and fibrin, kidney fragments were snap frozen in liquid nitro-
gen, and 2 pm cryostat sections were incubated with monospe-
cific, fluorescein-labelled goat anti-mouse IgG (heavy and light
chains), goat anti-mouse C3 serum (both from Cappel Labora-
tories, West Chester, Pennsylvania, USA), rabbit anti-goat Ig
(Nordic, Tilburg, The Netherlands) absorbed with 500 mg/mi
lyophylized non-immune mouse serum, and rabbit anti-human
fibrinogen, cross reacting with mouse fibrinogen (Dako, Copen-
hagen, Denmark). The sections were examined in a Leitz
fluorescence microscope equipped with a Ploemopak epi-illu-
mination and the staining intensity was recorded semiquantita-
tively (grading 0 to 4+) as earlier described [14].
For detection of macrophages in glomeruli, 6 tm cryostat
sections of the kidneys were incubated with a monoclonal
antibody of rat origin F4/80 (kindly provided by Dr. S. Gordon,
Oxford, England, UK), directed against murine macrophages
[15]. After further incubations with biotinylated rabbit anti-rat
Ig (Vector Laboratories, Burlingame, California, USA, diluted
1:200 in PBS 1% BSA) and peroxidase-labeled streptavidin
(Vector) color was developed with diaminobenzidine, and sec-
tions were counterstained with hematoxylin. Prior to the first
incubation endogenous biotin activity was inhibited by consec-
utive applications of avidin and biotin blocking solutions (Vec-
tor) according to the instructions of the manufacturer. Macro-
phages were counted in all glorneruli present in the cryostat
sections, their number varying from 20 to 30.
Quantitation of glomerular antibody binding
In vivo glomerular binding of undigested rabbit anti-GBM
antibodies and F(ab')2 fragments was measured by injecting
different doses of 1251 labeled samples of these antibodies in
groups of age-matched B 10.D2 new mice with and without
PMN depletion. For comparison of the binding of antibody in
PMN depleted (irradiated) and PMN normal mice a dose was
chosen that in the dose-response study had resulted in consid-
erable albuminuria (8 mg of rabbit anti-GBM antibody, inducing
an albuminuria of 4766 2089 jsg (mean SD, N = 6) in the 18
hour period from 6 to 24 hr after injection). Radiolabeled F(ab')2
fragments were injected both in equal protein quantities (8 mg)
and in equimolar doses (4 mg). Control mice were injected with
8 mg 1251 labeled non-immune rabbit IgG. We then determined
the amount of bound antibody in isolated glomeruli, using a
modification of the method of Gauthier and Mannik [16]. For
this purpose the mice were anaesthetized at one hour after
injection of the 125j labeled antibodies and the kidneys were
perfused in situ with 0.01 M PBS, pH 7.4, via a catheter in the
abdominal aorta, until they visually blanched. After this we
slowly infused Ito 2 ml of a solution containing 1.25 g magnetic
iron oxide (Fe304; BDH, Poole, UK) suspended in 100 ml PBS.
Within 60 seconds or less, localization of the iron in the
glomeruli could be macroscopically observed by the appear-
ance of small black spots on the surface of the kidneys against
a gradually darkening background. The kidneys were taken out,
pooled, homogenized through a 90 m stainless steel sieve, and
washed with PBS. For removal of suspended small clumps of
iron particles the homogenate was allowed to sediment in
conical polypropylene tubes (3 x 15') after which the superna-
tant was discarded. The final pellet was resuspended in 50 ml
PBS in a polypropylene tube and placed against one pole of a
strong permanent magnet (magnetic inductance of 0.3 Tesla),
causing accumulation of the iron-loaded glomeruli against the
wall of the tube within 10 to 20 seconds, and allowing removal
of the supernatant containing non-glomerular structures with a
pipette. The glomeruli were resuspended in PBS and washing,
followed by magnetic collection, was repeated three times. For
counting of the glomeruli and measurement of the bound
radiolabel 10 aliquots of the final glomerular suspension were
spread on a white 0.8 m Selectron filter with a diameter of 25
mm (Schleicher and Schull, Dassel, FRG). The filters were
placed on a glass slide, and covered with a covergiass, after
which the total number of black stained glomeruli on the filter
were counted twice microscopically with use of an ocular grid.
All filters contained 300 to 400 glomeruli each with less than 5%
contaminating structures, most of these being tubuli or sporadic
iron containing vascular fragments. Radioactivity of the
counted giomeruli on 10 filters was measured in a gamma
counter. Glomerular binding was expressed as pmol of bound
specific antibody per kidney by using the equation: counts per
minute per giomerulus x 12,000/number of glomeruli x specific
activity (cpm/pmol) [16—18].
Statistical analysis
Significance of differences between the various groups was
determined by the Wilcoxon test. P values of less than 0.05
were considered significant. All values are expressed as mean
SD.
Results
The nephritogenic properties of the goat anti-GBM antise-
rum, that was also used in the current study, have been
described before [4, 5]. The nephritogenic effect of the pooled
rabbit antisera was tested by injecting groups of 9 B 10.D2 new
mice with increasing amounts of antibody (2, 4, 8, and 16 mg).
The resulting albuminuria, as measured in 18-hour urine sam-
ples, and the histological lesions in the kidneys are summarized
in Table 1. The effects of both sera were found to be closely
comparable.
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Table 1. Albuminuna and glomerular lesions in Bl0.D2 new mice after injection of undigested rabbit anti-mouse GBM serum and F(ab')2
fragments
Injected Dose No. of Albuminuria PMNs per Deposits in capillary wallc
antiserum mg animals ttg/I8 hra glomerulus" Rabbit IgG C3
Undigested 2 6 671 212 4.0 1.1 +++ ++
RaM-GBM 4 6 1490 931 4.4 1.0 +++ ++
8 6 1490 2089 5.1 1.0 ++
16 5 5910 527 4.7 0.4 ++
F(ab')2 16 5 94 27 1.0 0.3 +++ —
None — 8 36 5 0.2 0.1
a Mean albuminuria (± SD) in urine collected from 6 to 24 hours after injection of the antiserum
b Mean values (± SD) in 40 glomeruli of 3 mice per observation point at 2 hours after injection of the antiserum
Linear staining with anti-rabbit IgG and fine granular staining with anti-mouse C3 at 2 hours after i.v. injection
Table 2. Effects of total body irradiation (7.5 Gy) in B10.D2 new and B10.D2 old micea
Bl0.D2 young BlO.D2 old
Irradiated Controls Irradiated Controls
PMNS/id 36 24 (12)1) 1111 494 (10) 36 4d (7) 838 383 (10)
Mononuclear cells/id 234 128d (9) 7657 997 (10) 200 64d (7) 8023 1807 (10)
Platelets x l0/,4 449 83d (12) 858 156 (10) 579 208d (7) 762 79 (10)
Serum creatinine pmol/iiter 34 5 (3) 29 7 (9) 30 4 (3) 29 5 (4)
Serum urea mmoi/liter 8.0 1.7 (3) 9.6 0.9 (3) 7.7 1.1 (3) 9.1 1.2 (4)
Serum albumin g/liter 24 1 (3) 25 2 (9) 28 1 (3) 25 2 (4)
Serum complement U/mi 1026 74 (3) 1554 244 (6) ND <10 (6)
Albuminuria pg/18 hrc 60 47 (6) 31 12 (60) ND 21 10 (60)
a All values, if not stated otherwise, determined at day 4 after irradiation
b Number of mice tested in parentheses
Albuminuria at day 5 after irradiation
d Significant difference between irradiated and control animals (P < 0.05)
PMN depletion by total body irradiation
Previous studies have shown that TBI is a reliable and
relatively simple method to induce PMN depletion in mice, and
has important advantages over other methods such as treatment
with anti-PMN serum [10]. The maximum effect of TB! on
circulating PMNs is seen from day 3 after irradiation, and
PMNs remain at very low levels for at least seven days. Table
2 shows the numbers of PMNs, mononuclear leukocytes, and
platelets in the peripheral blood in the B1O.D2 new and B10.D2
old mice at day 4 after TBI of 7.5 Gy. The induced granulopenia
in both strains was well below 100/jil, which can be regarded as
the upper limit of effective PMN depletion in mice, and per-
sisted through day 8 after irradiation, that is, till the end of the
experiments (data not shown). Parallel to the depletion of
PMNs a similar decrease in numbers of mononuclear leuko-
cytes was seen. The separate effects on lymphocytes and
monocytes were not tested, because the differentiation between
these cells, which is normally already difficult, was further
impaired by moderate degrees of nuclear pyknosis due to the
irradiation. Only a moderate decrease in platelet counts was
found at day 4 after irradiation, consistent with our earlier
findings that the effect of TBI on platelet counts develops more
slowly [10]. TB! alone had no effect on the physiological
albuminuria, that is seen in most murine strains. Pathological
albuminuria was defined as albuminuria of more than the mean
physiological value plus two standard deviations, that is, more
than 55 p.g/l8 hr. TB! did not affect renal function as determined
by serum creatinine and urea levels, and had no influence on the
complement levels in the complement-normal Bl0.D2 young
mouse strain (Table 2).
The influence of PMN depletion on the effect of injection of
anti-GBM serum in complement-normal and C5-deficient
mice
Figure 1 shows the effect of PMN depletion on the albumin-
uria in 18 hour samples of urine, collected 6 to 24 hours after
injection of goat anti-mouse GBM serum in complement-normal
B10.D2 new and C5-deficient B10.D2 old mice. After injection
of a low dose (5.6 mg), the albuminuria in irradiated animals
remained at levels below (B10.D2 new mice) or just above
(B lO.D2 old mice) physiological values, being 38 26 (N = 22)
and 70 41 gI18 hr (N = 11), respectively. Also after injection
of a high dose of antibody (22.5 mg) the albuminuria was
markedly reduced to 176 154 tg (N = 18) in BlO.D2 new and
378 348 rg (N = 11) in B10.D2 old mice, as compared to the
albuminuria in control mice of the same strains (10,484 5460
p.g [N = 27] and 4127 1909 jig [N = 181). At four days after
injection of the antibody the albuminuria in irradiated B 10.D2
new mice was 28 7 jig/18 hr after injection of the low dose (N
6) and 84 37 j.tg/18 hr after injection of the high dose (N =
4), showing that albuminuria also remained low at later stages.
Former experiments showed that also in non-irradiated mice
the albuminuria at day 4 is 20 to 60% lower than that at day 1
[5].
Injection of goat anti-GBM serum caused both in B10.D2 new
and B 10.D2 old mice glomerular lesions, histologically charac-
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new old
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Fig. 1. Influence of PMN depletion on the albuminuria in BlO.D2 new
and C5-deflcient B1O.D2 old mice, measured from 6 to 24 hours after
injection of 5.6 mg or 22.5 mg goat anti-mouse GBM serum. Mice were
depleted of PMNs by total body irradiation (7.5 Gy) at day —4. The
upper limit of physiological albuminuria, calculated as the mean albu-
minuria plus two standard deviations, in untreated mice is 55 g/l8 hr.
Symbols are: (0) control; (U) irradiated.
terized by accumulation of PMNs in the capillary vessels (Fig.
2B), followed by fibrin deposition and necrosis. Immunohisto-
logically an immediate, linear deposition of the injected anti-
body along the GBM and a transient localization of C3 could be
seen, preceding the deposition of fibrin thrombi. In the irradi-
ated groups the binding of the goat antibody to the GBM, as
estimated semiquantitatively in immunofluorescence, was un-
impaired, but no PMN accumulation was seen (Fig. 2A), no
inflammatory lesions nor necrosis did occur, and no fibrin
deposition could be found (Table 3, Fig. 3). No differences were
seen between the histological lesions of B lO.D2 new and the
CS-deficient Bl0.D2 old mice.
In a previous study we found that in this model of anti-GBM
nephritis complement activation does not play an essential role,
since its depletion by treatment with cobra venom factor had no
effect on either the albuminuria, the PMN influx, or the other
histological lesions in Bl0.D2 new or Bl0.D2 old mice [5]. It
seemed, therefore, that in this murine model the PMNs, which
are present in large numbers in the glomeruli at two hours after
injection of the antibody, are not attracted to the GBM by
activated complement, but probably adhere by binding of their
Fe receptors to the deposited heterologous antibody. To test
this assumption we injected F(ab')2 fragments of the goat
anti-mouse GBM serum in doses that were comparable to doses
of the undigested antibody. Table 4 shows that injection of
F(ab')2 fragments of the antiserum caused an albuminuria that
was only slightly above the physiological level, and that also the
PMN accumulation in the glomeruli was markedly reduced in
comparison to that after injection of undigested antiserum.
Injection of F(ab ')2 fragments of the rabbit anti-GBM antiserum
in a high dose gave comparable results (Table 1). In immuno-
fluorescence the binding of the F(ab')2 antibodies to the GBM
was similar to that of undigested antibody. In these mice we
saw no deposition of C3, at two hours in contrast to the
maximal staining at two hours in the groups that received the
undigested antiserum (Tables 1 and 4). However, at 24 hours
after injection C3 deposits were also present in the F(ab')2-
treated group. Histologically, the glomeruli of the mice that
received the F(ab')2 fragments did not show necrosis or depo-
sition of fibrin.
To exclude the possibility that the considerable decreases in
albuminuria in PMN depleted mice were caused by a local effect
of the TBI on the capillary walls, we tested the effect of
injection of antibody in B 10.D2 young mice that were irradiated
with 7.5 Gy only on the renal region. For determination of the
radiation field we performed intravenous pyelography in 14
mice, and from these findings defined the renal region as the
part of the body from the processus xyphoideus to 2 cm caudal
from that point. At day 4 the mice were injected with anti-GBM
antibody, and after six hours were placed in metabolic cages for
18 hours, similar to the other experimental groups. Renal tissue
was taken for histology at 0, 2, and 24 hours after injection of
antibody. The results are given in Table 5. Renal irradiation
alone did induce neutropenia at day 4(174 100 per pi, N =6),
but when these mice were injected with anti-GBM serum the
number of circulating PMNs quickly increased to values of 449
252 and 600 131 per pJ at two hours and 24 hours,
respectively. The glomerular influx of PMNs at two hours was
similar to that in mice with normal PMN counts. Renal irradi-
ation alone did not induce albuminuria, while injection of
anti-GBM serum caused an increase comparable to that in
non-irradiated mice.
Injection of anti-GBM serum did not significantly affect renal
function in irradiated mice or in controls, since from two hours
to four days after injection serum levels of creatinine, urea and
albumin remained in the same ranges as those given in Table 2.
Although we found earlier that complement does not play a
substantial role in this model we also tested the CH5O titers of
complement in BlO.D2 new mice during the period of the
experiment, and found no significant differences from the levels
in untreated and non-irradiated controls.
Glomerular binding of anti-GBM antibody and F(ab')2
fragments in normal and irradiated mice
The glomerular binding of the rabbit anti-GBM antibody is
shown in Figure 4. Intravenous injection of 8 mg of undigested
antibody in normal mice resulted in a specific binding of 55.6
4.2 pmol/kidney. In irradiated mice the same dose of rabbit
antiserum resulted in a binding of 45.9 3.3 pmollkidney. The
glomeruli of mice given an equimolar dose (4 mg) of F(ab')2
fragments or an equal protein dose (8 mg) of F(ab')2 fragments
of the rabbit anti-mouse GBM antibodies showed a lower
binding of 36.5 3.6 and 48.7 3.6 and pmollkidney, respec-
tively. Injection of 8 mg of non-immune rabbit IgG caused only
background binding (1.3 1.0 pmol/kidney).
Numbers of macrophages in the glomerular tuft
In glomeruli of normal mice macrophages can only sporadi-
cally be demonstrated; they are in numbers of one macrophage
per 20 to 25 glomeruli. In contrast with the prominent increase
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Fig. 2. Influx of PMNs in glomeruli at 2 hours after injection of 22.5 mg goal anti-mouse GBM in PMN depleted B1O.D2 new mice (A) and
non-irradiated controls (B). (PAS, x800).
Table 3. Histological and immunohistological findings in glomeruli of irradiated (TBI 7.5 Gy) and non-irradiated B 10.D2 new mice after
injection of goat and anti-mouse GBM antiseruma
Dose of
GaM-GBM
serum
mg
Time
after
injection
hr
Number of PMNs
per glomerulus
mean SD
Deposits in capillary wall
Goat IgGe Mouse C3d Fibrin
Irradiated Controls Irradiated Controls Irradiated ControlsIrradiated Controls
5.6 0 0.0 0.1±0.1 — — — — — —
2 0.3±0.4 3.5±1.1 ++++ ++++ ++ ++
6 0.1±0.0 ND ++++ ++++ + ND — ND
24 0.0 0.2±0.1 ++++ ++++ + + — ++
22.5 0 0.0 0.1 0.1 — — — — — —
2 0.3±0.3 4.3±1.2 ++++ ++++ ++ ++ — +
6 0.2 ND ++++ ND ++ ND — ND
24 0.0 0.1±0.1 ++++ ++++ + + — +++
a Comparable results were obtained in B10.D2 old mice.
b Counted in 40 glomeruli per mouse in 3 mice per observation point.
C Linear staining with anti-goat IgG.d Fine granular staining with anti-mouse C3 in the capillary walls.
of PMNs at two hours after injection of both goat and rabbit
anti-GBM antibodies the number of macrophages in the glomer-
uli, as counted in immunostaining, remained very low, being in
a range of one macrophage per 6 to 14 glomeruli, and at 24 hours
after injection this number had not increased.
Discussion
Our results show that TBI with resulting PMN depletion
greatly or totally prevented both the albuminuria and the
histological lesions that in control mice immediately followed
the injection of goat or rabbit anti-GBM serum. That this effect
was not the result of the reaction of the renal tissue itself to the
TBI was illustrated by the unchanged large albuminuria in mice
that received similar antibody treatment with irradiation on the
kidneys only. Our data strongly suggest that the damage to the
glomerular vessels, leading to the protein leakage and tissue
destruction induced by i.v. injection of anti-GBM antibody, was
effected in this model by the PMNs that accumulate in the
glomeruli and are present in large numbers two hours after
injection of the antibody. From our previous observations that
cobra venom factor treatment did not alter the reaction, and
that CS-deficient B l0.D2 old mice showed reactions that are not
essentially different from those in the complement-normal con-
genic strain [5], we concluded that the PMNs were not attracted
to the glomerular vessels by chemoattractant complement fac-
tors, but that the granulocytes probably bound to the deposited
anti-GBM antibody by their Fc receptors. The finding that
injection of F(ab')2 fragments of the antibody induced consid-
erably less PMN accumulation was consistent with this hypoth-
esis. The pivotal role of the PMNs was also underlined by the
finding that injection of the F(ab')2 fragments of the antibody
did not result in albuminuria and glomerular tissue destruction
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Fig. 3. Immunofluorescence findings after injection of 22 .5 mg of goat anti-mouse GBM antibody in PMN depleted BJO.D2 new mice. A. Linear
binding of goat immunoglobulins to the capillary wall. B. Deposition of mouse C3 along the capillary wall in a fine granular pattern at 2 hours after
injection of GaM-GBM. C. Absence of fibrin deposits in the glomeruli at 24 hours after injection of GaM-GBM serum. D. Focal and segmental
deposits of fibnn at 24 hours after injection in non-irradiated controls (x640).
such as that which occurs after injection of equivalent molar
doses of the non-digested antibody.
From the binding studies with labeled antibodies and F(ab')2
fragments, it can be concluded that the absence of albuminuria
after injection with F(ab')2 fragments of the rabbit anti-mouse
GBM antibody cannot be due to absence of specific binding
caused by the experimental procedures. The binding of the
antibody was also not substantially impaired by TB!, since
irradiated mice showed a specific glomerular binding that was
82% of that in non-irradiated controls. The decrease in glomer-
ular binding with equimolar doses of F(ab')2 fragments, that
was nearly restored when equal amounts of F(ab')2 proteins
were given, might be explained either by the more rapid
disappearance from the circulation of these fragments after
injection compared to the intact IgG [19], or by alterations in
the antigen binding capacity of the F(ab')2 fragments.
Among the many experimental models of anti-GBM nephritis
this is the first one that is complement independent, but PMN
dependent in its heterologous phase. Only the group of Naish et
al [20—22] reported PMN dependent/complement independent
induction of glomerular damage in anti-GBM nephritis. How-
ever, their data do not refer to the heterologous phase, but to an
accelerated autologous phase in a model of sheep anti-GBM
nephritis in rabbits. In all other PMN dependent models of the
heterologous phase the granulocyte accumulation seems to be a
consequence of complement activation. Decomplementation
before the administration of the anti-GBM antibodies in rats and
rabbits inhibits the proteinuria and the infiltration of PMNs [2,
23, 24]. While no other examples of a complement independent/
PMN dependent mechanism can be found in experimental
glomerulonephritis, there is evidence that it can occur in other
situations. We have found previously that in a model of acute
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Table 4. Albuminuna and glomerular lesions in B10.D2 new mice after injection of F(ab')2 fragments of goat anti-mouse GBM serum
(GaM-GBM)
Injected Dose No. of Albuminuria PMNs per
Deposits in capillary wall
Goat Mouse
antiserum mg animals itg/18 hra glomerulust' IgGc C3"
F(ab')2 0.4 3 80 54 1.0 0.2 ++ —
GaMGBMe
Undigested
1.6
6.2
11.2
5.6
3
3
3
19
64 22
70 20
70 10
1248 453
1.1 0.5
0.6 0.2
0.7 0.2
3.9 1.2
+++
++++
++++
++++
—
—
—
+
GaM-GBM 22.5 27 10,484 5460 5,0 0.6 ++++ ++
Non-immune
Goat-IgG 5.6 5 89 61 0.4 0.1 — —
None — 30 31 12 0.1 0.1 — —
a Albuminuria measured in urine collected from 6 to 24 hr after injection of the antiserumb Mean values SD in 40 glomeruli of 3 mice per observation point at 2 hours after injection of the antiserum
C Linear staining with anti-goat IgG at 2 hours after i.v. injectiond Fine granular staining with anti-mouse C3 in the capillary walls at 2 hours after i.v. injection
The approximate equivalent dose of undigested antiserum can be calculated by multiplying the dose of the F(ab')2 fragments by a factor 2 (see
text)
Table 5. Comparison of effects of TBI and local renal irradiat ion (7.5 Gy) in B10.D2 new mice
Irradiation
GaM.GBMa
22.5 mg
Circulating
PMNs per ,Llb
mean SD
PMNs per
glomerulusc
Albuminuria
g/18 hid
Total body
Renal region
None
—
+
—
+
—
+
36 24 (l2)
24 16 (3)
174 100 (6)
449 252 (3)
1111 495 (10)
ND
0.0 (3)
0.3 0.3 (3)
0.1 0.1 (3)
4.4 0.8 (2)
0.1 0.1 (6)
4.3 1.2 (3)
60 47 (6)
176 154 (18)
62 46(9)
7153 1678 (9)
31 12(30)
5024 2121 (6)
a Intravenous injection at day 4 after irradiationb PMNs were counted at day 4 after irradiation and (if antibody was administered) at 2 hours after i.v. injection
C Mean values at SD in 40 glomeruli per mouse at 2 hours after injection of antibodyd Albuminuria measured in urine collected from 6 to 24 hours after injection of antibody
e Numberof mice tested in parentheses
antibody-mediated skin graft rejection, the accumulation of
PMNs at the graft site after injection of specific antibody is also
not diminished by complement depletion [251.
Our conclusion, that complement plays no essential role in
the initial damage, is in apparent contradiction with the immu-
nohistological findings as summarized in Table 3 and 4, where
deposition of C3 can be demonstrated between 2 and 24 hours
after injection of the antibody. However, in our preceding study
with CoVF treated mice, C3 was not demonstrable in the serum
and IF with anti-C3 serum was negative at all times, while the
albuminuria and glomerular lesions were identical to those in
the control groups. This leads to the conclusion that comple-
ment fixation is not essential for the pathologic reaction to
occur. In the groups that received F(ab')2 fragments of the
antiserum the appearance of C3 was retarded, being negative at
two hours (Table 4) and prominent at 24 hours (data not shown).
Generally F(ab')2 fragments are not expected to induce com-
plement activation along the classical pathway, but activation
of the alternative pathway by F(ab')2 fragments can occur [26,
27]. This activation may develop more slowly, which could
explain the maximal activity found at 24 hours. Still, also this
type of complement activation cannot be considered an impor-
tant factor in the pathogenesis of the glomerular lesions, since
70
60
50
40
30
>-a
0
E0.
R.lgG RaM.GBM RaM.GBM F(ab)2 Flab')2
8mg 8mg 8mg 4mg 8mgControl + 7.5 Gy
Fig. 4. Glomerular antibody binding measured one hour after injection
of rabbit anti-mouse GBM serum (RaM.GBM) into normal B1O.D2 mice
and irradiated mice, after injection of F(ab')2 fragments derived from
purified rabbit anti-mouse GBM antibodies, and of normal rabbit lgG
(nR.IgG). Data are expressed in pmol bound intact antibody or F(ab')2
fragments/kidney (mean SD). Each group consisted of 5 mice. All
differences in binding levels between the different groups are statisti-
cally significant (P 0.002) with exception of the difference in binding
of 8 mg undigested RaM.GBM in irradiated mice, and that of 8 mg
F(ab')2 fragments (columns 3 and 5).
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both the PMN accumulation and the albuminuria were mark-
edly reduced when compared to that in controls which received
similar amounts of undigested antiserum.
Theoretically it is possible that not only PMNs, but also
mononuclear cells play an important role in the immunologi-
cally induced reaction. Although some reports have described a
mixed mononuclear and neutrophil infiltrate in the first hours of
the heterologous phase of anti-GBM nephritis, it is generally
believed that lymphocytes or monocytes do not effect glomer-
ular injury in the early phase [1, 2]. There is only one report
suggesting that, in a rabbit anti-rat GBM nephritis, lymphocytes
are involved in the damage in the heterologous phase [28]. A
definite role for the monocyte in mediating capillary wall
damage has only been documented for the autologous phase of
anti-GBM nephritis [29—32]. In our model a role for monocytes!
macrophages seems unlikely. Morphologically and immunohis-
tologically the very few monocytic cells found in the glomerular
capillaries were by far outnumbered by the PMNs, especially in
the initial hours after the administration of the anti-GBM
antibodies, when the enhanced permeability of the capillary
wall was first seen. In addition, we have recently demonstrated
in a different model that the induction of albuminuria and
morphological lesions in the early phase is dependent on the
inflammatory effects of PMNs: in beige C57B1/6J,bglbg mice, in
which the PMNs are deficient in the neutral proteinases elastase
and cathepsin 0 [33], injection of the anti-mouse GBM antibod-
ies did not induce albuminuria, although the glomerular influx of
PMNs and the endothelial cell damage were comparable to
those in control C57B1/61+1+ mice. These findings can only be
explained by the enzyme deficiency in the PMNs of beige mice
and not by a defect in monocytes/macrophages, that are report-
edly normal both in number and enzyme activity in the beige
mutant [34].
Since the glomerular damage caused by the injection of the
antiserum is accompanied by platelet aggregation, thrombosis
and fibrin deposition, we also have to consider a mediating role
by platelets and the coagulation system, which could have been
affected by TB!. However, a primary role for platelets seems
even more unlikely than for mononuclear cells, since the
number of platelets was only moderately decreased at day 4
alter TB!, and the remaining 60 to 70% can be considered
sufficient to cause thrombosis when effectively triggered. In-
deed, we found in a model of acute antibody-mediated rejection
of skin grafts in the mouse, that a similar course of TB! did not
impair platelet function, as evidenced by uninhibited platelet
aggregation and coagulation after injection of specific antibody
[35]. Whether platelets or coagulation system become involved
secondarily to the PMN dependent induction of the inflamma-
tory reaction remains to be studied.
It would be elegant to corroborate our findings by more
specific elimination and reconstitution of PMNs, thus circum-
venting the effect of TBI on mononuclear cells and platelets and
possible other effector systems [24, 36]. An attractive approach
would be to induce a highly specific PMN depletion without
effects on other cells by using a specific anti-PMN serum. In a
former study we have found, however, that it is very difficult to
prepare relatively pure suspensions of murine PMNs, necessary
for immunization [10]. Experimentally-induced peritoneal ex-
sudates contain 10 to 30% mononuclear cells, and separation of
the granulocytes on the basis of selective sedimentation is not
possible in this species. Anti-mouse PMN serum prepared in
this way is only moderately and temporarily effective, while
treatment with the antiserum severely undermines the general
condition of the animals. The difficulty in preparing pure
suspensions of physiologically unaltered PMNs makes it also
impossible to perform reliable reconstitution experiments in
PMN depleted mice. An alternative approach is to reconstitute,
by bone marrow transplantation, functionally normal PMNs in
animals that are genetically deficient in enzymatic PMN activ-
ity. Our model in C57B116J bg/bg mice and syngeneic controls
[33] will enable us to perform these experiments.
From the literature on the heterologous phase of anti-GBM
nephritis it can be concluded that glomerular damage can be
brought about along three main pathways: it can be induced
either by the deposited antibody itself, by activated comple-
ment components, or by the complement-mediated attraction of
PMNs [1, 2]. There is evidence that the quantity of bound
antibody is important in determining which of the abovemen-
tioned mediator systems will prevail [37, 38]. The complement
independent/PMN dependent pathogenesis of glomerular dam-
age in our murine model adds a new pathway of mediation to
this already multivariable spectrum. In fact, the existence of
such a pathway has already been assumed by others [2]. Our
model will enable further studies of complement independent
induction of tissue damage by PMNs and may thereby give new
insight in the role of these cells in immunologically-induced
glomerulonephritis.
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